Skip to main content
. Author manuscript; available in PMC: 2020 Aug 25.
Published in final edited form as: BJU Int. 2010 Aug 27;107(3):416–424. doi: 10.1111/j.1464-410X.2010.09569.x

TABLE 1.

Clinical and pathological characteristics

Age (median), years N (male/female) Tumour size (median), cm Grade (median)
Normal human kidney (control) 50–60 (NA) 5 (4/1) None N/A
Oncocytoma 63–81 (78.5) 4 (2/2) 2.0–7.5 (3.75) N/A
ccRCC 36–79 (60.5) 21 (9/12) 1.3–13 (5.5) 1–4 (2.5)
Non-ccRCC* 51–70 (62) 5 (3/2) 2.1–7 (5.0) 1–3 (2)
mRCC 35–84 (63) 9 (5/4) 2.5–12 (5.0) 2–4 (3)
*

Non-ccRCC cohort consists of patients with papillary RCC (two), chromophobe eosinophilia RCC (one), leiomyosarcoma (one) and haemangiopericytoma (one).